arrow_back Back to App

Accelerated Drug Approval for Coronavirus Therapies from Other Countries

This act aims to speed up access to coronavirus drugs already approved and safe in other countries. This allows citizens to receive new therapies faster, provided they meet specific safety and efficacy criteria. The approval process is set to take a maximum of 180 days.
Key points
Coronavirus drugs approved in selected countries may become available faster in the U.S.
Proof of drug safety, effectiveness, and manufacturer's production capability is required.
The act applies to drugs for coronavirus or other diseases with epidemic potential.
Approval decisions are to be made within 180 days of application submission.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_2983
Sponsor: Sen. Braun, Mike [R-IN]
Process start date: 2021-10-07
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

ADAPT for COVID Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_2983.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-10-07.

What are the main provisions?

Key points include:

  • Coronavirus drugs approved in selected countries may become available faster in the U.S.
  • Proof of drug safety, effectiveness, and manufacturer's production capability is required.
  • The act applies to drugs for coronavirus or other diseases with epidemic potential.
  • Approval decisions are to be made within 180 days of application submission.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Braun, Mike [R-IN].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health